title: Liver transplantation for unresectable hepatocellular carcinoma in normal livers.
abstract: OBJECTIVE
  The role of liver transplantation in the treatment of hepatocellular carcinoma in livers without fibrosis/cirrhosis (NC-HCC) is unclear. We aimed to determine selection criteria for liver transplantation in patients with NC-HCC.
  
  
  METHODS
  Using the European Liver Transplant Registry, we identified 105 patients who underwent liver transplantation for unresectable NC-HCC. Detailed information about patient, tumor characteristics, and survival was obtained from the transplant centers. Variables associated with survival were identified using univariate and multivariate statistical analyses.
  
  
  RESULTS
  Liver transplantation was primary treatment in 62 patients and rescue therapy for intrahepatic recurrences after liver resection in 43. Median number of tumors was 3 (range 1-7) and median tumor size 8 cm (range 0.5-30). One- and 5-year overall and tumor-free survival rates were 84% and 49% and 76% and 43%, respectively. Macrovascular invasion (HR 2.55, 95% CI 1.34 to 4.86), lymph node involvement (HR 2.60, 95% CI 1.28 to 5.28), and time interval between liver resection and transplantation < 12 months (HR 2.12, 95% CI 0.96 to 4.67) were independently associated with survival. Five-year survival in patients without macrovascular invasion or lymph node involvement was 59% (95% CI 47-70%). Tumor size was not associated with survival.
  
  
  CONCLUSIONS
  This is the largest reported series of patients transplanted for NC-HCC. Selection of patients without macrovascular invasion or lymph node involvement, or patients ≥ 12months after previous liver resection, can result in 5-year survival rates of 59%. In contrast to HCC in cirrhosis, tumor size is not a predictor of post-transplant survival in NC-HCC.
authors.affiliation: Queen Elizabeth Hospital, Birmingham, United Kingdom.
authors.forename: Hynek
authors.initials: H
authors.lastname: Mergental
authors.forename: Rene
authors.initials: R
authors.lastname: Adam
authors.forename: Bo-Goran
authors.initials: BG
authors.lastname: Ericzon
authors.forename: Piotr
authors.initials: P
authors.lastname: Kalicinski
authors.forename: Ferninand
authors.initials: F
authors.lastname: Mühlbacher
authors.forename: Krister
authors.initials: K
authors.lastname: Höckerstedt
authors.forename: Jürgen L
authors.initials: JL
authors.lastname: Klempnauer
authors.forename: Styrbjörn
authors.initials: S
authors.lastname: Friman
authors.forename: Christoph E
authors.initials: CE
authors.lastname: Broelsch
authors.forename: Georges
authors.initials: G
authors.lastname: Mantion
authors.forename: Carlos
authors.initials: C
authors.lastname: Fernandez-Sellez
authors.forename: Bart
authors.initials: B
authors.lastname: van Hoek
authors.forename: Josef
authors.initials: J
authors.lastname: Fangmann
authors.forename: Jacques
authors.initials: J
authors.lastname: Pirenne
authors.forename: Paolo
authors.initials: P
authors.lastname: Muiesan
authors.forename: Alfred
authors.initials: A
authors.lastname: Königsrainer
authors.forename: Darius F
authors.initials: DF
authors.lastname: Mirza
authors.forename: Jan
authors.initials: J
authors.lastname: Lerut
authors.forename: Olivier
authors.initials: O
authors.lastname: Detry
authors.forename: Yves-Ptrice
authors.initials: YP
authors.lastname: Le Treut
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Mazzaferro
authors.forename: Florian
authors.initials: F
authors.lastname: Löhe
authors.forename: Marina
authors.initials: M
authors.lastname: Berenguer
authors.forename: Pierre-Alain
authors.initials: PA
authors.lastname: Clavien
authors.forename: Xavier
authors.initials: X
authors.lastname: Rogiers
authors.forename: Jacques
authors.initials: J
authors.lastname: Belghiti
authors.forename: Laslo
authors.initials: L
authors.lastname: Kóbori
authors.forename: Patrizia
authors.initials: P
authors.lastname: Burra
authors.forename: Philippe
authors.initials: P
authors.lastname: Wolf
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Schareck
authors.forename: Przemyslaw
authors.initials: P
authors.lastname: Pisarski
authors.forename: Aksel
authors.initials: A
authors.lastname: Foss
authors.forename: Franco
authors.initials: F
authors.lastname: Filipponi
authors.forename: Marek
authors.initials: M
authors.lastname: Krawczyk
authors.forename: Martin
authors.initials: M
authors.lastname: Wolff
authors.forename: Jan M
authors.initials: JM
authors.lastname: Langrehr
authors.forename: Keith
authors.initials: K
authors.lastname: Rolles
authors.forename: Neville
authors.initials: N
authors.lastname: Jamieson
authors.forename: Wim C J
authors.initials: WC
authors.lastname: Hop
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Porte
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D015996:Survival Rate